# Conopco Inc. d/b/a Unilever – FDA Inspection, Jul 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/conopco-inc-dba-unilever/07417907-a7f0-4218-af73-c15a1890d659
Source feed: FDA_Inspections

> FDA inspection 1326098 of Conopco Inc. d/b/a Unilever, July 13, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326098
- Company Name: Conopco Inc. d/b/a Unilever
- Inspection Date: 2026-07-13
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 5

## Related Documents

- FDA Inspection 1172861 - 2022-05-27
- [FDA Inspection 989403 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/conopco-inc-dba-unilever/f498f0da-bbcb-4fb3-a791-1fb87adc13ee)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-z-weigman/fcf79bb1-87cc-476c-a1af-758ef0126ee9)

Company: https://www.keypedia.com/companies/conopco-inc-dba-unilever/f742261e-b37a-43b6-afd4-98d63b24d0da

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7